Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 2/3
×
INDUSTRY
×
Albumin-Bound Paclitaxel
×
Clear all
Filters
3
NCT05254171
2024-11-06
ASPIRE
Panbela Therapeutics, Inc.
Phase 2/3
Recruiting
600 enrolled
NCT01881230
2019-02-21
tnAcity
Celgene
Phase 2/3
Completed
191 enrolled
22 charts